Literature DB >> 16476495

A modelling study of the potential influence of low dose hypersensitivity on radiation treatment planning.

Henriette B Honoré1, Søren M Bentzen.   

Abstract

BACKGROUND AND
PURPOSE: Low dose hyper-radiosensitivity (HRS) has been observed in both normal tissues and tumours. This modelling study explores the possible impact of HRS on radiation treatment planning. PATIENTS AND METHODS: The interplay between volume-effect and HRS was studied in an idealized comparison of partial versus whole organ irradiation. In the further studies, CT scans of three previously scanned patients were used to estimate normal tissue complication probability (NTCP) for the kidneys after a conformal and a conventional treatment plan with and without consideration of HRS.
RESULTS: Idealized treatment plans were compared as pairs of a conventional and a conformal plan both treating the same target volume to the same dose per fraction. Contour maps of the difference in NTCP between paired plans showed a strong dependence on the magnitude of both the volume effect and the HRS effect. For more clinically realistic treatment plans with NTCP calculated for the kidney, the balance between the sparing due to the LQ effect and the increased sensitivity due to the HRS effect was dependent on both the dose distribution and the fractionation.
CONCLUSIONS: HRS may potentially affect radiotherapy treatment planning and the relative importance of HRS is larger in a tissue or organ with a pronounced volume effect. If HRS is expressed in some normal tissues or organs, this could offset much of the sparing predicted by the LQ formalism. However, in some clinical situations the NTCP calculated with correction for HRS may still be lower than the NTCP calculated from the uncorrected physical doses.

Entities:  

Mesh:

Year:  2006        PMID: 16476495     DOI: 10.1016/j.radonc.2006.01.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Low dose hyper-radiosensitivity in human lung cancer cell line A549 and its possible mechanisms.

Authors:  Xiaofang Dai; Dan Tao; Hongge Wu; Jing Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

2.  The role of DNA damage repair and Chk2 protein in hyper-radiosensitivity of lung adenocarcinoma A549 cells.

Authors:  Hongge Wu; Qitian Chen; Yong Zhang; Gang Wu; Rui Meng; Jing Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

3.  Low-dose radiation hyper-radiosensitivity in multicellular tumour spheroids.

Authors:  D Guirado; M Aranda; M Ortiz; J A Mesa; L I Zamora; E Amaya; M Villalobos; A M Lallena
Journal:  Br J Radiol       Date:  2012-10       Impact factor: 3.039

4.  Extracting the normal lung dose-response curve from clinical DVH data: a possible role for low dose hyper-radiosensitivity, increased radioresistance.

Authors:  J J Gordon; K Snyder; H Zhong; K Barton; Z Sun; I J Chetty; M Matuszak; R K Ten Haken
Journal:  Phys Med Biol       Date:  2015-08-21       Impact factor: 3.609

5.  A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.

Authors:  Bo Wang; Dongping Li; Corinne Sidler; Rocio Rodriguez-Juarez; Natasha Singh; Mieke Heyns; Yaroslav Ilnytskyy; Roderick T Bronson; Olga Kovalchuk
Journal:  Oncotarget       Date:  2015-04-30

6.  Cell division cycle 25 homolog c effects on low-dose hyper-radiosensitivity and induced radioresistance at elevated dosage in A549 cells.

Authors:  Yanxia Zhao; Yingshan Cui; Jun Han; Jinghua Ren; Gang Wu; Jing Cheng
Journal:  J Radiat Res       Date:  2012-06-06       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.